The role of polymers in detection and isolation of circulating tumor cells

Circulating tumor cells (CTCs) in blood, known to be responsible for cancer metastasis, have been widely investigated as a biomarker for diagnosis and prognosis of metastatic cancer. In many of the studies, polymers have been commonly used to enable or enhance separation of CTCs; however, existing reviews do not focus on the role that has been played by polymers in the CTC detection field. In this review, we systematically classify the roles of polymers in representative CTC detection mechanisms, such as physical property-based filtration, separation in solution, and surface capture. This review highlights recent advances in the CTC detection through incorporation of polymers, which is a highly promising way to achieve clinically significant detection of rare CTCs.

[1]  David T. Eddington,et al.  Channel surface patterning of alternating biomimetic protein combinations for enhanced microfluidic tumor cell isolation. , 2012, Analytical chemistry.

[2]  Mehmet Toner,et al.  Antibody-functionalized fluid-permeable surfaces for rolling cell capture at high flow rates. , 2012, Biophysical journal.

[3]  Seungpyo Hong,et al.  Dendrimer-mediated multivalent binding for the enhanced capture of tumor cells. , 2011, Angewandte Chemie.

[4]  Hengyi Xu,et al.  Antibody conjugated magnetic iron oxide nanoparticles for cancer cell separation in fresh whole blood. , 2011, Biomaterials.

[5]  Kai Li,et al.  Herceptin functionalized polyhedral oligomeric silsesquioxane - conjugated oligomers - silica/iron oxide nanoparticles for tumor cell sorting and detection. , 2011, Biomaterials.

[6]  Klaus Pantel,et al.  Circulating Tumors Cells as Biomarkers: Progress Toward Biomarker Qualification , 2011, Cancer journal.

[7]  Kazunori Hoshino,et al.  Microchip-based immunomagnetic detection of circulating tumor cells. , 2011, Lab on a chip.

[8]  Jaap M J den Toonder,et al.  Circulating tumor cell isolation and diagnostics: toward routine clinical use. , 2011, Cancer research.

[9]  Mateus Crespo,et al.  Reporting the Capture Efficiency of a Filter-Based Microdevice: A CTC Is Not a CTC Unless It Is CD45 Negative—Letter , 2011, Clinical Cancer Research.

[10]  Susana Campuzano,et al.  Micromachine-enabled capture and isolation of cancer cells in complex media. , 2011, Angewandte Chemie.

[11]  Mehmet Toner,et al.  Circulating tumor cells: approaches to isolation and characterization , 2011, The Journal of cell biology.

[12]  Seungpyo Hong,et al.  Direct measurements on CD24-mediated rolling of human breast cancer MCF-7 cells on E-selectin. , 2011, Analytical chemistry.

[13]  Bo Lu,et al.  3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood , 2011, Biomedical microdevices.

[14]  J. Zuo,et al.  Highly sensitive identification of cancer cells by combining the new tetrathiafulvalene derivative with a β-cyclodextrin/multi-walled carbon nanotubes modified GCE. , 2010, The Analyst.

[15]  K. Isselbacher,et al.  Isolation of circulating tumor cells using a microvortex-generating herringbone-chip , 2010, Proceedings of the National Academy of Sciences.

[16]  S. Groshen,et al.  Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells , 2010, Clinical Cancer Research.

[17]  Seungpyo Hong,et al.  Enhanced tumor cell isolation by a biomimetic combination of E-selectin and anti-EpCAM: implications for the effective separation of circulating tumor cells (CTCs). , 2010, Langmuir : the ACS journal of surfaces and colloids.

[18]  T. Fehm,et al.  Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial , 2010, Clinical Cancer Research.

[19]  Daniel T Chiu,et al.  Deformability considerations in filtration of biological cells. , 2010, Lab on a chip.

[20]  Ekaterina I. Galanzha,et al.  Nanotechnology‐based molecular photoacoustic and photothermal flow cytometry platform for in‐vivo detection and killing of circulating cancer stem cells , 2009, Journal of biophotonics.

[21]  Thomas Kelly,et al.  In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells. , 2009, Nature nanotechnology.

[22]  G. Braun,et al.  Cell-targeted self-assembled DNA nanostructures. , 2009, Journal of the American Chemical Society.

[23]  Stefan Sleijfer,et al.  Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer. , 2009, Cancer treatment reviews.

[24]  Swee Jin Tan,et al.  Microdevice for the isolation and enumeration of cancer cells from blood , 2009, Biomedical microdevices.

[25]  E. Gillies,et al.  Surface functionalization of nanomaterials with dendritic groups: toward enhanced binding to biological targets. , 2009, Journal of the American Chemical Society.

[26]  J. Massagué,et al.  Molecular basis of metastasis. , 2008, The New England journal of medicine.

[27]  L. Hartmann,et al.  Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor‐specific fluorescent ligands , 2008, International journal of cancer.

[28]  D. Krag,et al.  Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients , 2008, Breast Cancer Research.

[29]  Ruud H. Brakenhoff,et al.  Detection, clinical relevance and specific biological properties of disseminating tumour cells , 2008, Nature Reviews Cancer.

[30]  S. Chien,et al.  Tumor cell cycle arrest induced by shear stress: Roles of integrins and Smad , 2008, Proceedings of the National Academy of Sciences.

[31]  S. Digumarthy,et al.  Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.

[32]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[33]  Siyang Zheng,et al.  Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. , 2007, Journal of chromatography. A.

[34]  P. Paterlini-Bréchot,et al.  Circulating tumor cells (CTC) detection: clinical impact and future directions. , 2007, Cancer letters.

[35]  Philip S Low,et al.  In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry , 2007, Proceedings of the National Academy of Sciences.

[36]  Brigitte Rack,et al.  Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System , 2007, Clinical Cancer Research.

[37]  Miqin Zhang,et al.  Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. , 2006, Journal of biomedical materials research. Part A.

[38]  Mario Pazzagli,et al.  Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection. , 2006, Human pathology.

[39]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[40]  R. Weissleder,et al.  Cell-specific targeting of nanoparticles by multivalent attachment of small molecules , 2005, Nature Biotechnology.

[41]  Thommey P. Thomas,et al.  Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. , 2005, Cancer research.

[42]  Jonathan W. Uhr,et al.  Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.

[43]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[44]  P. Kitov,et al.  On the nature of the multivalency effect: a thermodynamic model. , 2003, Journal of the American Chemical Society.

[45]  Thommey P. Thomas,et al.  Design and Function of a Dendrimer-Based Therapeutic Nanodevice Targeted to Tumor Cells Through the Folate Receptor , 2002, Pharmaceutical Research.

[46]  Nathan Kohler,et al.  Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. , 2002, Biomaterials.

[47]  George M. Whitesides,et al.  Designing a polyvalent inhibitor of anthrax toxin , 2001, Nature Biotechnology.

[48]  Yuan-chuan Lee,et al.  Affinity enhancement by multivalent lectin–carbohydrate interaction , 2000, Glycoconjugate Journal.

[49]  George M Whitesides,et al.  Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors. , 1998, Angewandte Chemie.

[50]  L. Kiessling,et al.  Strength in numbers: non-natural polyvalent carbohydrate derivatives. , 1996, Chemistry & biology.

[51]  L R Coney,et al.  Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. , 1992, Cancer research.

[52]  M. Telen,et al.  CD44--a molecule involved in leukocyte adherence and T-cell activation. , 1989, Immunology today.

[53]  P. Möller,et al.  Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. , 1987, Cancer research.

[54]  L. Weiss,et al.  A fluid mechanical analysis of the velocity, adhesion, and destruction of cancer cells in capillaries during metastasis , 1984, Cell Biophysics.

[55]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .

[56]  Seungpyo Hong,et al.  The Binding Avidity of a Nanoparticle-based Multivalent Targeted Drug Delivery Platform , 2022 .